Inflammatory bowel disease, or IBD, is an umbrella term referring to a group of disorders that cause inflammation of the intestines, including ulcerative colitis, diverticular disease and perianal fistula.
Diverticulosis is a common disease of the large intestine characterized by pouches in the colon that bulge outward through weak spots in the colon musculature.
Cystoplasty using gastrointestinal segments is a common treatment for patients with end-stage bladder disease.
Three new therapy options, including two novel medications, showed promise in the treatment of irritable bowel syndrome (IBS), according to research presented at Digestive Disease Week 2007 (DDW).
One primary research focus in GI disorders is how and why the system reacts to certain foods or other stimulants; specifically, researchers are investigating the primary factors responsible for regulating digestion.
The biotechnology company Alimentary Health today announced results from two studies that demonstrate the anti-inflammatory activity of a natural probiotic bacterial strain of human origin, Bifantis? (Bifidobacterium infantis 35624), in models of arthritis and Salmonella infection.
Research presented at Digestive Disease Week? 2007 (DDW?) demonstrates the potential of statins, important cholesterol management therapies, for improving the management of hepatitis C ? a disease that affects nearly four million Americans.
Hepatitis C not only affects more than 3.9 million Americans, but continues to impact and influence the occurrence of related inflammatory conditions.
Research presented at Digestive Disease Week? 2007 (DDW?) introduces unique methods for evaluating patients with non-alcoholic fatty liver disease (NAFLD).
Michigan based meat company has initiated recall of 129,000 pounds of beef products in 15 states in the United States because of possible E. coli contamination.